Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

McCoy, Karen S.; Quittner, Alexandra L.; Oermann, Christopher M.; Gibson, Ronald L.; Retsch-Bogart, George Z.; Montgomery, A. Bruce

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

By Karen S. McCoy, Alexandra L. Quittner, Christopher M. Oermann, Ronald L. Gibson, George Z. Retsch-Bogart and A. Bruce Montgomery

Abstract

Rationale: The effectiveness and safety of aztreonam lysine for inhalation (AZLI) in patients with cystic fibrosis (CF) on maintenance treatment for Pseudomonas aeruginosa (PA) airway infection was evaluated in this randomized, double-blind, placebo-controlled study

Topics: B. Cystic Fibrosis

Publisher: American Thoracic Society

OAI identifier: oai:pubmedcentral.nih.gov:2577727

Provided by: PubMed Central

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://www.pubmedcentral.nih.g... (external link)

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

Abstract

Suggested articles